CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors

Moderna enters in vivo CAR-T with autoimmune asset

Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026

Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies

TScan Therapeutics Advances TSC-101 Toward Pivotal Trial

FREE to Attend for Biopharma, Academics & Non-Profit Organizations*

Setting the Benchmark for Efficacy & Safety in CAR-T Therapy

Setting the Benchmark for Efficacy & Safety in CAR-T Therapy

By | 21 April 2026

Learnings on dual CAR-T design, why targeting CD20xCD22 simultaneously
Rationale for NHL indication
Present the eti-cel preliminary data